The EUCAST subcommittee on the role of whole genome sequencing (WGS) in antimicrobial susceptibility testing (AST) has published its second review: The role of whole genome sequencing in antimicrobial…
The rationale document for gepotidacin has been published. This follows the recent publication of gepotidacin breakpoints in version 16.0 of the breakpoint tables for Escherichia coli, Staphylococcus…
Breakpoints for antimicrobial agents against the following species are proposed: Clostridium innocuum, Clostridium ramosum, Clostridium septicum, Clostridium tertium, Cutibacterium avidum, Finegoldia…
Following a review of the comments submitted to the recent consultation on carbapenem breakpoints for Gram-negative bacteria, a further proposal on meropenem breakpoints on Pseudomonas and …
Updated versions of MIC:ZD correlations have been published for relevant bacterial species. These correlations form the basis of validation of zone diameter criteria for disk diffusion methodology.
A public consultation on revised carbapenem (with and without inhibitors) and ceftazidime-avibactam breakpoints against Gram-negative bacteria has been published. The revised breakpoints are presented…
Version 16.0 of the breakpoint tables include new breakpoints for gepotidacin against E. coli, S. saprohyticus and E. faecalis, revised breakpoints for trimethoprim and trimethoprim-sulfamethoxazole…
A webinar will be held on 20 January 2026 (12:00-13:00 CET) to highlight any changes in the new breakpoint tables. Members of EUCAST will expand on the changes made to version 16.0 of the breakpoint…